| Application no. and date | 17177123.1 (espacenet) (Federated) (European Patent Register), 20110706 | | Patent/reg. no. and date | DK/EP 3243526, 20191127 | | Publication date | 20171115 | | Priority no. and date | US 361789 P, 20100706 | | EP pub. no. and date |
EP 3243526 20171115 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals S.A., Rue de l'Institut, 89
1330 Rixensart, BE | | Applicant ref. no. | 163245 | | Inventor | GEALL, Andrew, Novartis Vaccines And Diagnostics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097, US,
MANDL, Christian, Novartis Vaccines And Diagnostics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097, US,
RAMSAUER, Katrin, Novartis Vaccines and Diagnostics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097, US,
OTTEN, Gillis, Novartis Vaccines and Diagnostics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 39/00 (2006.01) , A61K 39/12 (2006.01) | | Title | LEVERING AF RNA TIL AT UDLØSE FLERE IMMUNSIGNALVEJE | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
